US 10 year yields have retreated as oil prices eased, which has taken some pressure off inflation worries and put renewed attention on companies with healthier growth prospects. In that context, a focused screener for expected earnings growth and solid finances is especially interesting. This article walks through three stocks from the Healthy high growth potential screener that stand out and explains why they may deserve a closer look now.

The three stocks highlighted below are only a small sample, as the full screen identified 271 more companies with similarly compelling growth and financial stories that are not covered here. To go straight to the source and identify your own highest conviction ideas, analyze the Healthy high growth potential screener.

Oscar Health (OSCR)

Oscar Health is a US based healthcare technology company that sells health insurance plans to individuals, families, and small businesses, and also runs digital platforms that help other insurers and brokers manage enrollment and member engagement. The company has a market cap of about US$9.1b, which puts it firmly in mid cap territory for US investors.

Oscar Health is attracting attention because its tech heavy model and growing +Oscar platform are now being matched by hard numbers, including recent quarters of meaningful profitability and a raised 2026 earnings outlook. At the same time, the stock still trades on a modest P/S multiple relative to peers, even as membership tops 2 million and new products like the ICHRAx platform aim to pull in employer clients. The catch is that the business still faces real pressure from medical cost trends, policy uncertainty around ACA subsidies, and visible insider selling, so the risk reward balance needs closer inspection before taking a strong view.

Oscar Health’s tech heavy insurance model and new profitability are starting to align, yet the market still seems cautious. Get the full picture with the 2 key rewards and 2 important warning signs

Build your own healthy growth shortlist

Oscar Health and the two other stocks in this article all surfaced from a single Simply Wall St screener, but your edge comes from tailoring the search to your own style. Use our flexible Screener to mix filters like growth, valuation, and balance sheet strength, or start with one of our curated Investing Ideas.

Dutch Bros (BROS)

Dutch Bros is a US based drive thru coffee chain that sells handcrafted beverages under brands such as Dutch Bros Coffee and Blue Rebel, supported by a mix of company operated and franchised shops. The company has a market cap of about US$12.3b, which places it in the larger end of the mid cap range for US consumer stocks.

Investors are watching Dutch Bros because it is pairing rapid store growth with improving financials, including 13 straight quarters of positive same store sales and Q2 2026 revenue of US$550.85 million versus US$415.81 million a year earlier. Earnings are forecast to grow strongly; yet the stock already trades on a rich valuation, so the real question is whether expanding drive thru coverage, digital loyalty, and higher margin specialty drinks can offset rising labor costs, a relatively narrow food menu, and intense coffee competition over time.

Dutch Bros is already scaling fast, and the market debate around how far this growth story can run is just getting started. See how the current roll out, margins and valuation compare in the analysis report for Dutch Bros

Chime Financial (CHYM)

Chime Financial is a US based fintech that offers app based banking and payments tools, including spending accounts, debit cards, paycheck services, credit building products and savings features, as well as Chime Workplace benefits for employers. The company serves millions of consumers through its mobile platform and employer partnerships and has a market cap of about US$9.8b.

Investors are watching Chime Financial because it sits at the center of app based everyday banking, with 9.1 million active members and products like MyPay, SpotMe and Chime Card that can lift revenue per user as adoption broadens. Recent results showed positive net income and adjusted EBITDA alongside raised 2026 revenue guidance. Analysts have published forecasts that anticipate strong earnings growth in the coming years. At the same time, the company remains reliant on external funding rather than deposits, has a rich P/S multiple versus peers and is expanding into higher risk credit, so tighter regulation, higher loss rates or funding stress could quickly change the story.

Chime Financial’s accelerating member base and rising engagement tools hint at a much bigger earnings story that many investors may be underestimating. See how analysts frame that growth with the analyst forecasts for Chime Financial

Seeking Fresh Alternatives Before Others Catch On

Market momentum can shift quickly and the best breakout stories often fly under the radar for now. Scan fresh stock ideas before the crowd catches them and act now.

• Target income that can hold up when markets wobble by reviewing the curated 9 dividend fortresses to see which payouts still look supported by solid balance sheets.
• Spot early movers in critical infrastructure by screening the curated 36 power grid technology and infrastructure stocks to see which companies could benefit if grid upgrades accelerate while it matters.
• Ride the next wave of automation by checking the hand picked 36 robotics and automation stocks to assess which businesses already show real revenue from robots, not just hype.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.